Precigen
PGEN
7.54
-0.01
-0.13%
Precigen
US · PGEN
#2527 by market cap
Listed 1970
7.54
-0.01
-0.13%
Live - 5344 symbols - heartbeat 32s ago
· 2026-10-08 07:00
Pre-market
7.50
-0.53%
After-hours
7.56
+0.27%
Overnight
7.50
-0.53%
- Market cap
- 2.70B
- P/E (TTM)i
- -7.05
- P/Bi
- 61.80
- EPSi
- -1.37
- Div yieldi
- 0.00%
- 52W posi
- 76%
Reader sentiment
Are you bullish or bearish on PGEN?
Anonymous reader poll. Unscientific, not investment advice.
About Precigen
Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.
- Founded
- 1998
- CEO
- Dr. Helen Sabzevari, PhD
- Employees
- 47
- Headquarters
- Germantown, Maryland, United States of America
- Fiscal year end
- 12-31
- Website
- precigen.com
Company profile
- Exchange
- US
- Symbol
- PGEN
- Market-cap rank
- #2527
- Listing date
- 1970-01-01
- Market cap
- 2.70B
- Float cap
- 1.47B
- Shares out
- 358.04M
- Float shares
- 194.60M
Sectors & themes
Quote time 2026-10-08 07:00:08 · For reference only, not investment advice and not tailored to your situation.